Castellum, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Castellum, Inc. on July 3, 2024, covering events occurring on July 1, 2024. The filing primarily addresses the entry into material definitive employment agreements with new executive leadership and changes to Board of Director compensation.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive and director compensation structures.
Material Changes and Agreements
- CEO Appointment: Glen R. Ives was appointed President and Chief Executive Officer effective July 1, 2024.
- CEO Compensation (Glen R. Ives):
- Annual base salary: $300,000.
- Annual cash incentive: Up to 50% of base salary, contingent on performance thresholds.
- Discretionary bonus: Up to 50% of base salary, at the Compensation Committee's discretion.
- Equity: 750,000 stock options at an exercise price of $0.212, vesting ratably over one year, expiring June 30, 2031.
- Executive Compensation (Jay O. Wright):
- Term: Nine-month employment agreement.
- Annual base salary: $270,000.
- Benefits: $4,000 monthly health insurance stipend and an annual discretionary bonus.
- Severance Provisions: Both executives are eligible for severance equal to their base salary for up to 12 months if terminated without cause or if they resign for good reason, subject to a mutual release agreement.
- Board Compensation Reduction: Effective July 1, 2024, annual cash compensation for independent directors was reduced to $30,000. Additional stipends apply for committee chairs ($15,000 for Chair of Board/Audit; $10,000 for Chair of Compensation/Nominating).
- Director Equity: Independent directors received grants for 250,000 stock options each at the closing stock price on July 1, 2024.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on future business performance. The primary risk disclosed relates to the financial obligations of the new employment contracts and the potential dilution from the issuance of 1,000,000 new stock options (750,000 to the CEO and 250,000 to each independent director).
Investor Verification Checklist
- Verify the total number of independent directors to calculate the aggregate equity grant impact (250,000 options per director).
- Review the specific performance thresholds required for Mr. Ives to earn the 50% performance-based cash incentive.
- Confirm the closing stock price on July 1, 2024, to determine the exercise price for the director stock options.
- Assess the impact of the new executive salaries and potential severance liabilities on the company's cash burn rate.